14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $3.25 $4.87 Thursday, 2nd May 2024 AVXL stock ended at $3.76. This is 1.90% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 3.86% from a day low at $3.63 to a day high of $3.77.
90 days $3.25 $6.15
52 weeks $3.25 $10.31

Historical Anavex Life Sciences Corp. prices

Date Open High Low Close Volume
Feb 22, 2023 $10.03 $10.20 $9.99 $10.11 751 523
Feb 21, 2023 $10.38 $10.45 $9.97 $10.00 1 127 474
Feb 17, 2023 $10.41 $10.58 $10.25 $10.58 728 908
Feb 16, 2023 $10.33 $10.60 $10.25 $10.42 1 000 894
Feb 15, 2023 $10.48 $10.63 $10.29 $10.47 738 908
Feb 14, 2023 $10.43 $10.72 $10.27 $10.60 917 469
Feb 13, 2023 $10.55 $10.67 $10.40 $10.50 724 739
Feb 10, 2023 $10.39 $10.62 $10.18 $10.54 775 552
Feb 09, 2023 $11.04 $11.10 $10.40 $10.41 1 164 400
Feb 08, 2023 $11.51 $11.90 $10.92 $10.93 1 417 825
Feb 07, 2023 $11.00 $11.93 $10.78 $11.75 2 028 123
Feb 06, 2023 $11.24 $11.59 $11.11 $11.11 1 306 897
Feb 03, 2023 $11.11 $11.59 $11.05 $11.26 1 069 259
Feb 02, 2023 $11.09 $11.71 $10.97 $11.37 1 430 566
Feb 01, 2023 $10.89 $11.22 $10.57 $10.99 1 170 949
Jan 31, 2023 $10.13 $10.89 $10.06 $10.87 1 369 166
Jan 30, 2023 $10.74 $10.76 $9.84 $10.05 1 922 059
Jan 27, 2023 $10.52 $10.69 $10.41 $10.56 601 500
Jan 26, 2023 $10.91 $10.99 $10.39 $10.52 594 548
Jan 25, 2023 $10.52 $10.83 $10.32 $10.79 871 783
Jan 24, 2023 $10.38 $10.91 $10.22 $10.72 1 154 251
Jan 23, 2023 $10.33 $10.58 $10.13 $10.47 970 684
Jan 20, 2023 $10.22 $10.41 $9.98 $10.30 981 763
Jan 19, 2023 $9.99 $10.24 $9.65 $10.10 1 116 600
Jan 18, 2023 $10.56 $10.75 $10.06 $10.13 1 206 547
Click to get the best stock tips daily for free!

About Anavex Life Sciences Corp.

Anavex Life Sciences . Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinica... AVXL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT